Wolfe Research begins coverage on biotech, names Alpine Immune Sciences as Top Pick By Investing.com

Published on 15 Feb 2024 on Investing.com

Wolfe Research begins coverage on biotech, names Alpine Immune Sciences as Top Pick

Read the rest of the article

Start tracking your investments with Statfolio

Roivant's shares gained 4% in afternoon trading, while its subsidiary Arbutus rose more than 17%....

Reuters via Yahoo News 3 Apr 2024

, opens new tab fell 4% on Wednesday after a U.S. judge issued an order that strengthened Arbutus...

Reuters 3 Apr 2024

Stocks that are trading heavily or have substantial price changes on Tuesday: Tesla, UnitedHealth...

Washington Post 2 Apr 2024

Roivant Sciences Ltd. (NASDAQ: ROIV ), a biopharmaceutical company, has announced the authorizati...

Investing.com 2 Apr 2024

Roivant Sciences Ltd (NASD:ROIV) will replace Sunrun Inc. (NASD:RUN) in the S&P MidCap 400, and...

WWTI Watertown 26 Mar 2024

Wolfe Research begins coverage on biotech, names Alpine Immune Sciences as Top Pick

Investing.com 15 Feb 2024

Roivant Sciences Ltd. (NASDAQ:ROIV), a pharmaceutical company, has reported its third-quarter...

Investing.com 15 Feb 2024

Tourlite Capital Management, an investment management firm, released its fourth quarter 2023 inve...

Insider Monkey via Yahoo Finance 15 Feb 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2023 Earnings Call Transcript February 13, 2024 Roivant Sc...

Insider Monkey via Yahoo Finance 14 Feb 2024

Eric Venker, President & COO of Roivant Sciences Ltd (NASDAQ:ROIV), executed a sale of 96,950 sha...

GuruFocus.com via Yahoo Finance 10 Feb 2024